Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
X Bioscience PCLBKK:XBIO PB Ratio is 2.59 as of Aug. 25, 2026, which is 52% above its 10-year median of 1.70. The stock has 6 warning signs investors should review. Among 328 Restaurants companies, X Bioscience PCL ranks worse than 53.05% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-25), X Bioscience PCL's share price is ฿0.07. X Bioscience PCL's Book Value per Share for the quarter that ended in Mar. 2026 was ฿0.03. Hence, X Bioscience PCL's PB Ratio of today is 2.59.
The historical rank and industry rank for X Bioscience PCL's PB Ratio or its related term are showing as below:
BKK:XBIO'
s PB Ratio Range Over the Past 10 Years
Min: 0.16 Med: 1.7 Max: 20.92
Current: 2.59
During the past 13 years, X Bioscience PCL's highest PB Ratio was 20.92. The lowest was 0.16. And the median was 1.70.
BKK:XBIO's PB Ratio is ranked worse than 53.05% of 328
companies
in the Restaurants industry
Industry Median: 2.45
vs BKK:XBIO: 2.59
During the past 12 months, X Bioscience PCL's average Book Value Per Share Growth Rate was -93.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -18.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -58.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -54.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of X Bioscience PCL was 25.00% per year. The lowest was -80.60% per year. And the median was -21.30% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
X Bioscience PCL PB Ratio Related Terms
X Bioscience PCL PB Ratio Historical Data
* Premium members only.
The historical data trend for X Bioscience PCL's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Restaurants subindustry, X Bioscience PCL's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
X Bioscience PCL PB Ratio vs Restaurants Industry
For the Restaurants industry and Consumer Cyclical sector, X Bioscience PCL's PB Ratio distribution charts can be found below:
* The bar in red indicates where X Bioscience PCL's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
X Bioscience PCL (BKK:XBIO) has a PB Ratio of 2.59 as of Aug. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on X Bioscience PCL and its competitors. This is 52% above median its historical median of 1.70. Over the past decade, X Bioscience PCL's PB Ratio has ranged from 0.16 to 20.92. According to the industry distribution chart, X Bioscience PCL ranks #174 out of 328 companies in the Restaurants industry, placing it in the top 53%.
Is X Bioscience PCL's PB Ratio too high?
X Bioscience PCL's current PB Ratio of 2.59 is 52% above median its 10-year median of 1.70. Over the past 10 years, this metric has ranged from a low of 0.16 to a high of 20.92. The Restaurants industry median PB Ratio is 2.45. X Bioscience PCL's value of 2.59 is 5.7% above this industry median. Based on the distribution chart, X Bioscience PCL ranks #174 out of 328 companies in the Restaurants industry, which is below the industry midpoint.
How does X Bioscience PCL's PB Ratio compare to SYY and USFD?
According to the Restaurants industry distribution chart, X Bioscience PCL ranks #174 out of 328 companies for PB Ratio. This places X Bioscience PCL in the lower half of its industry. The industry median PB Ratio is 2.45. X Bioscience PCL's value of 2.59 is 5.7% above this benchmark. Historically, X Bioscience PCL's own PB Ratio has ranged from 0.16 to 20.92 over the past decade. While the company's 10-year median is 1.70 vs. the industry median of 2.45, X Bioscience PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Restaurants company?
The median PB Ratio among Restaurants companies is 2.45, based on 328 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. X Bioscience PCL's current PB Ratio of 2.59 is 5.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on X Bioscience PCL and its competitors. For the Restaurants industry, the median PB Ratio is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. X Bioscience PCL's current PB Ratio is 2.59, which is 52% above median its own 10-year median of 1.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is X Bioscience PCL stock overvalued right now?
Based on GuruFocus' analysis, X Bioscience PCL (BKK:XBIO) is currently considered Possible Value Trap. The stock's GF Value™ is ฿0.10, compared to a current price of ฿0.07 — trading 30% below its estimated fair value. The current PB Ratio is 2.59, which is 52% above median its 10-year median of 1.70 and 5.7% above the Restaurants industry median of 2.45. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For X Bioscience PCL (BKK:XBIO), the current PB Ratio is 2.59 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
X Bioscience PCL, along with its subsidiaries, is mainly engaged in selling food and beverages by operating restaurants and bakery shops under the Le Boeuf, Kagonoya, Bake Cheese Tart, Croquant Chou ZakuZaku, and RAPL trademarks. Additionally, the Group is involved in the production and distribution of biological products. It operates in two business segments: the food and beverage sales segment, which generates maximum revenue, and the production and distribution of biological products segment. Geographically, the Group operates only in Thailand.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:XBIO has been successfully added to your 
